BTMD
biote·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 3
Bearish signal 1
High Gross Profit Margin
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About BTMD
Biote Corp.
A company that develops pharmaceuticals to treat hormonal imbalances in women and men
Healthcare Providers and Services
07/06/2020
08/29/2022
NASDAQ Stock Exchange
217
12-31
Common stock
1875 W. Walnut Hill Ln, #100, Irving, TX 75038
--
Biote Corp. was incorporated in Delaware on July 6, 2020. The company is a female-led company that operates a high-growth, differentiated medical practice construction business in the field of hormone optimization. The company trains practitioners on how to identify and treat early indicators of hormone-related aging conditions.
Earnings Call
Q1/2025
Estimate EPS0.13
Actual EPS0.37
Estimate Revenue47.25M
Actual Revenue48.99M
Biote's Q1 2025: Unraveling Contradictions on CDSS Impact, Sales Strategy, and GLP-1 Shortages
May 08,2025 07:33
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.13
Actual EPS0.1
Estimate Revenue49.54M
Actual Revenue48.90M
Biote Corp.'s Q2 2025 Earnings Call: Navigating Contradictions in Verticalization, Volume Declines, and Revenue Growth Expectations
Aug 11,2025 07:00
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
BTMD has released its 2025 Q3 earnings. EPS was reported at 0.22, versus the expected 0.12, beating expectations. The chart below visualizes how BTMD has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
BTMD has released its 2025 Q3 earnings report, with revenue of 47.96M, reflecting a YoY change of -6.67%, and net profit of 9.22M, showing a YoY change of -27.19%. The Sankey diagram below clearly presents BTMD's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
